Administration, Topical: The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example.Endophthalmitis: Suppurative inflammation of the tissues of the internal structures of the eye frequently associated with an infection.Vitreous Body: The transparent, semigelatinous substance that fills the cavity behind the CRYSTALLINE LENS of the EYE and in front of the RETINA. It is contained in a thin hyaloid membrane and forms about four fifths of the optic globe.Patents as Topic: Exclusive legal rights or privileges applied to inventions, plants, etc.Anterior Chamber: The space in the eye, filled with aqueous humor, bounded anteriorly by the cornea and a small portion of the sclera and posteriorly by a small portion of the ciliary body, the iris, and that part of the crystalline lens which presents through the pupil. (Cline et al., Dictionary of Visual Science, 4th ed, p109)Cyclosporine: A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed).Cyclosporins: A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection.Aqueous Humor: The clear, watery fluid which fills the anterior and posterior chambers of the eye. It has a refractive index lower than the crystalline lens, which it surrounds, and is involved in the metabolism of the cornea and the crystalline lens. (Cline et al., Dictionary of Visual Science, 4th ed, p319)Eye: The organ of sight constituting a pair of globular organs made up of a three-layered roughly spherical structure specialized for receiving and responding to light.Administration, Ophthalmic: Application of pharmaceutically active agents on the tissues of the EYE.Polymyxin B: A mixture of polymyxins B1 and B2, obtained from Bacillus polymyxa strains. They are basic polypeptides of about eight amino acids and have cationic detergent action on cell membranes. Polymyxin B is used for infections with gram-negative organisms, but may be neurotoxic and nephrotoxic.Polymyxins: Basic lipopeptide antibiotic group obtained from Bacillus polymyxa. They affect the cell membrane by detergent action and may cause neuromuscular and kidney damage. At least eleven different members of the polymyxin group have been identified, each designated by a letter.Societies, Pharmaceutical: Societies whose membership is limited to pharmacists.Internship, Nonmedical: Advanced programs of training to meet certain professional requirements in fields other than medicine or dentistry, e.g., pharmacology, nutrition, nursing, etc.Reference Books, Medical: Books in the field of medicine intended primarily for consultation.Pharmacists: Those persons legally qualified by education and training to engage in the practice of pharmacy.Education, Pharmacy, Graduate: Educational programs for pharmacists who have a bachelor's degree or a Doctor of Pharmacy degree entering a specific field of pharmacy. They may lead to an advanced degree.Colistin: Cyclic polypeptide antibiotic from Bacillus colistinus. It is composed of Polymyxins E1 and E2 (or Colistins A, B, and C) which act as detergents on cell membranes. Colistin is less toxic than Polymyxin B, but otherwise similar; the methanesulfonate is used orally.MonographBooksInjections: Introduction of substances into the body using a needle and syringe.Disposable Equipment: Apparatus, devices, or supplies intended for one-time or temporary use.Temperature: The property of objects that determines the direction of heat flow when they are placed in direct thermal contact. The temperature is the energy of microscopic motions (vibrational and translational) of the particles of atoms.Injections, Jet: The injection of solutions into the skin by compressed air devices so that only the solution pierces the skin.Body Temperature: The measure of the level of heat of a human or animal.Syringes: Instruments used for injecting or withdrawing fluids. (Stedman, 25th ed)Drug Delivery Systems: Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity.Body Temperature Regulation: The processes of heating and cooling that an organism uses to control its temperature.Needles: Sharp instruments used for puncturing or suturing.Equipment Design: Methods of creating machines and devices.Grooming: An animal's cleaning and caring for the body surface. This includes preening, the cleaning and oiling of feathers with the bill or of hair with the tongue.Phacoemulsification: A procedure for removal of the crystalline lens in cataract surgery in which an anterior capsulectomy is performed by means of a needle inserted through a small incision at the temporal limbus, allowing the lens contents to fall through the dilated pupil into the anterior chamber where they are broken up by the use of ultrasound and aspirated out of the eye through the incision. (Cline, et al., Dictionary of Visual Science, 4th ed & In Focus 1993;1(1):1)Astigmatism: Unequal curvature of the refractive surfaces of the eye. Thus a point source of light cannot be brought to a point focus on the retina but is spread over a more or less diffuse area. This results from the radius of curvature in one plane being longer or shorter than the radius at right angles to it. (Dorland, 27th ed)Cornea: The transparent anterior portion of the fibrous coat of the eye consisting of five layers: stratified squamous CORNEAL EPITHELIUM; BOWMAN MEMBRANE; CORNEAL STROMA; DESCEMET MEMBRANE; and mesenchymal CORNEAL ENDOTHELIUM. It serves as the first refracting medium of the eye. It is structurally continuous with the SCLERA, avascular, receiving its nourishment by permeation through spaces between the lamellae, and is innervated by the ophthalmic division of the TRIGEMINAL NERVE via the ciliary nerves and those of the surrounding conjunctiva which together form plexuses. (Cline et al., Dictionary of Visual Science, 4th ed)Lens Implantation, Intraocular: Insertion of an artificial lens to replace the natural CRYSTALLINE LENS after CATARACT EXTRACTION or to supplement the natural lens which is left in place.Descemet Membrane: A layer of the cornea. It is the basal lamina of the CORNEAL ENDOTHELIUM (from which it is secreted) separating it from the CORNEAL STROMA. It is a homogeneous structure composed of fine collagenous filaments, and slowly increases in thickness with age.Surgical Tape: A flat, flexible strip of material used to cover or fasten together damaged tissue.Corneal Topography: The measurement of curvature and shape of the anterior surface of the cornea using techniques such as keratometry, keratoscopy, photokeratoscopy, profile photography, computer-assisted image processing and videokeratography. This measurement is often applied in the fitting of contact lenses and in diagnosing corneal diseases or corneal changes including keratoconus, which occur after keratotomy and keratoplasty.Microsurgery: The performance of surgical procedures with the aid of a microscope.Trabecular Meshwork: A porelike structure surrounding the entire circumference of the anterior chamber through which aqueous humor circulates to the canal of Schlemm.Sclera: The white, opaque, fibrous, outer tunic of the eyeball, covering it entirely excepting the segment covered anteriorly by the cornea. It is essentially avascular but contains apertures for vessels, lymphatics, and nerves. It receives the tendons of insertion of the extraocular muscles and at the corneoscleral junction contains the canal of Schlemm. (From Cline et al., Dictionary of Visual Science, 4th ed)Intraocular Pressure: The pressure of the fluids in the eye.Anterior Eye Segment: The front third of the eyeball that includes the structures between the front surface of the cornea and the front of the VITREOUS BODY.Glaucoma, Open-Angle: Glaucoma in which the angle of the anterior chamber is open and the trabecular meshwork does not encroach on the base of the iris.Eye Diseases: Diseases affecting the eye.Ciliary Body: A ring of tissue extending from the scleral spur to the ora serrata of the RETINA. It consists of the uveal portion and the epithelial portion. The ciliary muscle is in the uveal portion and the ciliary processes are in the epithelial portion.Point-of-Care Systems: Laboratory and other services provided to patients at the bedside. These include diagnostic and laboratory testing using automated information entry.Software: Sequential operating programs and data which instruct the functioning of a digital computer.User-Computer Interface: The portion of an interactive computer program that issues messages to and receives commands from a user.Computer Graphics: The process of pictorial communication, between human and computers, in which the computer input and output have the form of charts, drawings, or other appropriate pictorial representation.Algorithms: A procedure consisting of a sequence of algebraic formulas and/or logical steps to calculate or determine a given task.Family Practice: A medical specialty concerned with the provision of continuing, comprehensive primary health care for the entire family.Internet: A loose confederation of computer communication networks around the world. The networks that make up the Internet are connected through several backbone networks. The Internet grew out of the US Government ARPAnet project and was designed to facilitate information exchange.LaosComputational Biology: A field of biology concerned with the development of techniques for the collection and manipulation of biological data, and the use of such data to make biological discoveries or predictions. This field encompasses all computational methods and theories for solving biological problems including manipulation of models and datasets.Physician's Practice Patterns: Patterns of practice related to diagnosis and treatment as especially influenced by cost of the service requested and provided.Drug Approval: Process that is gone through in order for a drug to receive approval by a government regulatory agency. This includes any required pre-clinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance of the drug.United States Food and Drug Administration: An agency of the PUBLIC HEALTH SERVICE concerned with the overall planning, promoting, and administering of programs pertaining to maintaining standards of quality of foods, drugs, therapeutic devices, etc.Keratitis, Dendritic: A form of herpetic keratitis characterized by the formation of small vesicles which break down and coalesce to form recurring dendritic ulcers, characteristically irregular, linear, branching, and ending in knoblike extremities. (Dictionary of Visual Science, 3d ed)Keratitis, Herpetic: A superficial, epithelial Herpesvirus hominis infection of the cornea, characterized by the presence of small vesicles which may break down and coalesce to form dendritic ulcers (KERATITIS, DENDRITIC). (Dictionary of Visual Science, 3d ed)Ganciclovir: An ACYCLOVIR analog that is a potent inhibitor of the Herpesvirus family including cytomegalovirus. Ganciclovir is used to treat complications from AIDS-associated cytomegalovirus infections.Keratitis: Inflammation of the cornea.United StatesOrphan Drug Production: Production of drugs or biologicals which are unlikely to be manufactured by private industry unless special incentives are provided by others.Drug Labeling: Use of written, printed, or graphic materials upon or accompanying a drug container or wrapper. It includes contents, indications, effects, dosages, routes, methods, frequency and duration of administration, warnings, hazards, contraindications, side effects, precautions, and other relevant information.Safety-Based Drug Withdrawals: Removal of a drug from the market due to the identification of an intrinsic property of the drug that results in a serious risk to public health.
(1/59) Recent advances in ophthalmic drug delivery.

 (+info)

(2/59) Using fewer animals to identify chemical eye hazards: revised criteria necessary to maintain equivalent hazard classification.

 (+info)

(3/59) Distribution of propranolol in periocular tissues: a comparison of topical and systemic administration.

 (+info)

(4/59) The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity.

 (+info)

(5/59) Polymeric vectors for ocular gene delivery.

 (+info)

(6/59) Brimonidine tartrate-eudragit long-acting nanoparticles: formulation, optimization, in vitro and in vivo evaluation.

 (+info)

(7/59) The effect of dorzolamide 2% on circadian intraocular pressure in cats with primary congenital glaucoma.

 (+info)

(8/59) Effects of unilateral topical administration of 0.5% tropicamide on anterior segment morphology and intraocular pressure in normal cats and cats with primary congenital glaucoma.

 (+info)

*  Levomoprolol
... liquid chromatography-gas chromatography of the beta-blocker levomoprolol in plasma following ophthalmic administration". ...
*  Brinzolamide
... due to variable absorption from the stomach mucosa and an increased side-effect profile versus ophthalmic administration. The ... Sall KN, Greff LJ, Johnson-Pratt LR, et al.: Dorzolamide/timolol combination versus concomitant administration of brimonidine ... wheezing or trouble breathing Hypersensitivity to other sulfonamides Acute angle-closure glaucoma Concomitant administration of ...
*  Ron Link (patient advocate)
Ron Link first spoke in front of the U.S. Food and Drug Administration Ophthalmic Devices Panel about the need to address LASIK ...
*  Saline (medicine)
... after either ophthalmic or intravenous administration. However, ophthalmic use is done with sterile filtered drugs that is ... it does not correct hyponatremia as rapidly as administration of hypertonic saline does. Due to hypertonicity, administration ... Water privation combined with diuretic block does not produce as much risk of CPM as saline administration does; however, ... or ophthalmic, which is compared to intravenous use; By demonstration, the elimination of latanoprost acid from plasma is rapid ...
*  Keratoconus
In 2016, the US Food and Drug Administration approved riboflavin ophthalmic solution and KXL system for crosslinking based on ... Ophthalmic Hosp Rep and J R Lond Ophthalmic Hosp. 1859;9:157. Horner JF, Zur Behandlung des Keratoconus. Klinische ... Keratoconus is amongst the ophthalmic conditions that exhibit a scissor reflex action of two bands moving toward and away from ... Rubinfeld RS, Traboulsi EI, Arentsen JJ, Eagle RC (June 1990). "Keratoconus after penetrating keratoplasty". Ophthalmic Surgery ...
*  Sankara Nethralaya
... ophthalmic research and hospital administration. The institution offers wide-ranging programmes including allied health ... Sankara Nethralaya (SN) is a not-for-profit missionary institution for ophthalmic care (i.e., an eye hospital) in Chennai, ... Hospital Administration (MHA), etc... Vision Research Foundation (VRF) has, over the last two decades, been doing premier work ... the C U Shah Ophthalmic Postgraduate Training Center has been offering fellowship programmes in Vitreo-Retinal Surgery and ...
*  Government Medical College, Thiruvananthapuram
The limb center, mental hospital and ophthalmic hospital were brought under Medical College administration. Later in 1990s the ... The Mental Health Center is in Oolampara, Peroorkada and is under the administration of the college. With more than 150 inmates ... It was originated as a government ophthalmic hospital in 1905 and brought into the National Programme for Control of Blindness ... Expertise of the faculty and able administration with aids from the Central and State governments have helped maintain this ...
*  Palpebral fissure
978-0-683-08363-7. United States Food and Drug Administration (Nov. 2006). Xalatan® (latanoprost ophthalmic solution) 0.005% ( ... In animal studies, using four times the therapeutic concentration of the ophthalmic solution Latanoprost, the size of the ...
*  Geetanjali Medical College
Diploma courses Diploma in Radiography Diploma in Hospital Administration (DHA) Diploma in Ophthalmic Technician Diploma in ... Optometry) B.Sc.(Cardiac Perfusion) B.H.A. (Bachelor in Hospital Administration) Post Graduate courses MD (Biochemistry) MD ( ... Master in Hospital Administration) M.Sc. (Clinical Psychology) Doctorate Programmes Ph.D (Biochemistry) Ph.D (Physiology) Ph.D ...
*  Netarsudil
In the United States, the Food and Drug Administration has approved a 0.02% ophthalmic solution for the lowering of elevated ...
*  Ophthalmic
Ophthalmology Ophthalmic nerve Ophthalmic artery Ophthalmic veins Ophthalmic drug administration, as with eye drops See also: ... Ophthalmic means pertaining to the eye, and can refer to: ...
*  Papain
On September 23, 2008, the US Food and Drug Administration (FDA) warned companies to stop marketing ophthalmic balanced salt ... United States Food and Drug Administration, Department of Health and Human Services. The MEROPS online database for peptidases ...
*  Dermatologic and Ophthalmic Drugs Advisory Committee
Food and Drug Administration (FDA). The committee, consisting of members from academic and clinical dermatology, ophthalmology ... The Dermatologic And Ophthalmic Drugs Advisory Committee (DODAC) receives requests for technical and clinical evaluation of new ... the CDER and CBER divisions of the FDA about the advisability of approving new medications to treat dermatologic and ophthalmic ... Dermatologic And Ophthalmic Drugs Advisory Committee, official webpage: http://www.fda.gov/AdvisoryCommittees/ ...
*  List of soft contact lens materials
Ophthalmic Devices Panel" (PDF). www.fda.gov. FDA Division of Ophthalmic and Ear, Nose and Throat Devices. p. 97. Archived from ... Soft contact lenses are one of several types on the U.S. Market approved by the U.S. Food and Drug Administration for ... The U.S. Food and Drug Administration (FDA) classifies soft contact lenses into four groups for the U.S. Market. They are also ... The U.S. Food and Drug Administration (FDA) states that: Soft contact lenses are made of soft, flexible plastics that allow ...
*  Gwangju Health University
Technology Department of Ophthalmic Optics Department of Emergency Medical Technology Department of Health Administration ... of Physical Therapy Department of Radiological Technology Department of Dental Laboratory Technology Department of Ophthalmic ...
*  Retrometabolic drug design
Bodor, N.; Buchwald, P. (2005). "Ophthalmic drug design based on the metabolic activity of the eye: soft drugs and chemical ... Loteprednol etabonate, a soft corticosteroid designed and patented by Bodor received final Food and Drug Administration (FDA) ... currently the only corticosteroid approved by the FDA for use in all inflammatory and allergy-related ophthalmic disorders. Its ... oxime-based eye-targeting CDSs could replace the β-blockers currently used for ophthalmic applications. These retrometabolic ...
*  Prostaglandin F receptor
... ophthalmic solution termed Latisse, is approved by the US Food and Drug Administration to treat hypotrichosis of the eyelashes ... Finally, administration of PGF2α to mice causes an acute inflammatory response and elevated biosynthesis of PGF2α has been ...
*  Melphalan
Oral or intravenous; dosing varies by purpose and route of administration as well as patient weight. Melphalan Prescribing ... This is accomplished via transarterial catheter based slow pulsed infusion into the ophthalmic artery. ...
*  Post-LASIK ectasia
... for topical ophthalmic use For use with the KXL® System" (PDF). U.S. Food and Drug Administration. pp. 5-14. Ectasia After ... for topical ophthalmic use PHOTREXA (riboflavin 5'-phosphate ophthalmic solution) 0.146% ... "Highlights of Prescribing Information: PHOTREXA VISCOUS (riboflavin 5'-phosphate in 20% dextran ophthalmic solution) 0.146% ...
*  Peter Hersh
Ophthalmic Practice 1995; 13:126-133. Burnstein Y, Hersh PS. Photorefractive keratectomy following radial keratotomy. J Refract ... "ViewPoint™ CK System - P010018". Food and Drug Administration. Hersh, Peter. "Optics of Conductive Keratoplasty: Implications ... "Summary minutes of the ophthalmic devices panel meeting" (PDF). www.fda.gov. Retrieved November 30, 2001. " ... Food and Drug Administration (FDA) of the excimer laser for the correction of nearsightedness in the United States. Hersh was ...
*  Gatifloxacin
In China it is sold in tablet as well as in eye drop formulations.Ophthalmic anti-infectives are generally well tolerated. The ... Jerry Gurwitz in the same issue called for the Food and Drug Administration (FDA) to consider giving Tequin a black box warning ... Given as an eye drop, Gatifloxacin Ophthalmic Solution 0.3% & 0.5% cause very low systemic exposures. Therefore, the systemic ... certain adverse side effects Hypersensitivity Gatifloxacin is currently available in the US and Canada only as an ophthalmic ...
*  SNDT Women's University
Ophthalmic Technology, Medical Laboratory Technology, Electronics, Food Technology, Travel & Tourism, Apparel Manufacture & ... Medical Lab Technology Department of Apparel Manufacture and Design Department of Interior Design Department of Administration ... has 10 academic departments Department of Electronics Engineering Department of Food Technology Department of Ophthalmic ...
*  1918 New Year Honours
to the Administration, Northern Rhodesia Francis.Charles Jenkin, Deputy Superintendent, Special Police Reserve, Hong Kong ... James Francis Gordon Hopkins, Chief Inspector, Ministry of Finance Arthur Ferguson MacCallan FRCS Director of Ophthalmic ... Advisory Committee Francis Ernest Saville, Chief Administration Ofc., Leeds Special Constabulary Albert Edwin Sawday JP ... Ports and Lights Administration Lindsay Edward Bury, Inspector of Irrigation Frank Pears Watson, Inspector of State Buildings, ...
*  Eliakim Littell
His brother Squier Littell was a physician who eventually became surgeon to the Wills Ophthalmic Hospital of Philadelphia 1834- ... Congress during the administration of President Jackson. ...
*  Boro glycerine
Kumar, R. (1992) Social and preventive health administration p.357. APH Publishing ISBN 81-7024-454-4 Retrieved June 2011 ... Jaypee Brothers Publishers ISBN 81-7179-738-5 Retrieved June 2011 Norton, A. B. (1997) Ophthalmic Diseases & their Homeopathic ...
*  Andhra Medical College
Construction works of the Ophthalmic Block with 80 beds was completed in 1932. The Out Patient (OP) block and Casualty was ... In 1949, the Government of Madras took over its administration. The hospital has three units with 147 beds and has recently ...
Patent US4649047 - Ophthalmic treatment by topical administration of cyclosporin - Google Patents  Patent US4649047 - Ophthalmic treatment by topical administration of cyclosporin - Google Patents
By requiring systemic administration in cyclosporin treatment of opthalmic diseases not limited to the eye surface, a patient ... The cyclosporin may be topically administered as an ophthalmic drop or ophthalmic ointment containing an effective amount of ... Ophthalmic compositionn and method of using same. US4937078 *. Aug 26, 1988. Jun 26, 1990. Mezei Associates Limited. Liposomal ... Veterinary treatment of ophthalmic disease in animals using toptical tacrolimus. US20040121944 *. Dec 20, 2002. Jun 24, 2004. ...
more infohttp://www.google.com/patents/US4649047?dq=6,332,126
Single Administration Sustained Release Formats for Administration of Ophthalmic Medications to the Ocular Surface, Cornea and...  Single Administration Sustained Release Formats for Administration of Ophthalmic Medications to the Ocular Surface, Cornea and...
Single Administration Sustained Release Formats for Administration of Ophthalmic Medications to the Ocular Surface, Cornea and ... Single Administration Sustained Release Formats for Administration of Ophthalmic Medications to the Ocular Surface, Cornea and ... Shikha P Barman, Koushik Barman, Kevin Ward; Single Administration Sustained Release Formats for Administration of Ophthalmic ...
more infohttps://iovs.arvojournals.org/article.aspx?articleid=2270086
Pharmacokinetics and Safety of Topical Administration of Brimonidine Tartrate Ophthalmic Solution 0.025%. - Tabular View -...  Pharmacokinetics and Safety of Topical Administration of Brimonidine Tartrate Ophthalmic Solution 0.025%. - Tabular View -...
Pharmacokinetics and Safety of Topical Administration of Brimonidine Tartrate Ophthalmic Solution 0.025%.. The safety and ... Pharmacokinetics and Safety of Topical Administration of Brimonidine Tartrate Ophthalmic Solution 0.025%. ... Study of the Plasma Pharmacokinetics and Safety Following Topical Administration of Brimonidine Tartrate Ophthalmic Solution ... One drop of brimonidine tartrate ophthalmic solution 0.025% in each eye once at Visit 2 (Day 1) then four times daily (QID) ...
more infohttps://www.clinicaltrials.gov/ct2/show/record/NCT02039765?term=BRIMONIDINE
Long Term Administration Study of OPC-12759 Ophthalmic Suspension - Full Text View - ClinicalTrials.gov  Long Term Administration Study of OPC-12759 Ophthalmic Suspension - Full Text View - ClinicalTrials.gov
Long Term Administration Study of OPC-12759 Ophthalmic Suspension. The safety and scientific validity of this study is the ... Long Term Administration Study of OPC-12759 Ophthalmic Suspension in Dry Eye Patients. ... Experimental: OPC-12759 Ophthalmic suspension Instillation, 4times/day. Drug: OPC-12759 Ophthalmic suspension Instillation, ... The purpose of this study is to evaluate safety and efficacy of OPC-12759 ophthalmic suspension during 52 weeks in dry eye ...
more infohttps://clinicaltrials.gov/show/NCT00818324
Negligent Administration of Ophthalmic Anesthesia Causes Permanent Loss of Vision  Negligent Administration of Ophthalmic Anesthesia Causes Permanent Loss of Vision
... by Joseph O'Neill - March 7, 2017. ... Home / Expert Case Studies / Negligent Administration of Ophthalmic Anesthesia Causes Permanent Loss of Vision ... Administration Anesthesiology Blindness Cataract Surgery CRNA Medical Medical Malpractice Optometrist Optometry Retina Vision ... 1. Do you routinely administer ophthalmic anesthesia to patients like the one described above? ...
more infohttps://www.theexpertinstitute.com/case-studies/negligent-administration-ophthalmic-anesthesia-causes-permanent-loss-vision/
Comparison of Drug Concentrations in Human Aqueous Humor after the Administration of 0.3% Gatifloxacin Ophthalmic Gel, 0.3%...  Comparison of Drug Concentrations in Human Aqueous Humor after the Administration of 0.3% Gatifloxacin Ophthalmic Gel, 0.3%...
Comparison of Drug Concentrations in Human Aqueous Humor after the Administration of 0.3% Gatifloxacin Ophthalmic Gel, 0.3% ... Purpose: To investigate the penetration of 0.3% gatifloxacin ophthalmic gel, 0.3% gatifloxacin ophthalmic solution and 0.5% ... Keywords: aqueous humor, levofloxacin, gatifloxacin, ophthalmic gel, ophthalmic solution This is an open access article ... Gatifloxacin Ophthalmic Gel, 0.3% Gatifloxacin and 0.5% Levofloxacin Ophthalmic Solutions. Int J Med Sci 2015; 12(6):517-523. ...
more infohttp://www.medsci.org/v12p0517
Polymyxin B Sulfate eent Monograph for Professionals - Drugs.com  Polymyxin B Sulfate eent Monograph for Professionals - Drugs.com
Ophthalmic Administration. In fixed combination with other anti-infectives and corticosteroids, apply topically to the eye as ... Polymyxin B Sulfate Dosage and Administration. Administration. Apply topically to the eye or ear.a b c d e f g h i j k l ... Ophthalmic Ointments. Ophthalmic ointments may delay corneal healing.f k l. Sensitivity Reactions. Hypersensitivity Reactions. ... Bacterial Ophthalmic Infections. Polymyxin B and Neomycin Sulfates and Bacitracin Zinc. Ophthalmic Ointment Apply to the ...
more infohttps://www.drugs.com/monograph/polymyxin-b-sulfate-eent.html
Epinastine Hydrochloride Monograph for Professionals - Drugs.com  Epinastine Hydrochloride Monograph for Professionals - Drugs.com
Administration. Ophthalmic Administration. Apply topically to the eye as an ophthalmic solution.1 Not for injection or oral use ... Peak plasma concentrations attained approximately 2 hours after ophthalmic administration.1. Onset. Rapid onset (within 3-5 ... Ophthalmic. Solution. Tightly closed bottle at 15-25°C.1. Actions. * Inhibits the release of mediators (e.g., histamine) from ... Ophthalmic. Children ≥3 years of age: 1 drop of a 0.05% solution in each eye twice daily for up to 8 weeks.1 ...
more infohttps://www.drugs.com/monograph/epinastine-hydrochloride.html
Delayed corneal wound healing resulting from the administration of fluoroquinolone antibacterial ophthalmic solutions and its...  Delayed corneal wound healing resulting from the administration of fluoroquinolone antibacterial ophthalmic solutions and its...
Three types of antibacterial ophthalmic solutions, VEGAMOXTM 0.5% ophthalmic solution (MFLX), Cravit® 1.5% ophthalmic solution ... Conclusions: Delayed corneal wound healing resulting from the administration of three antibacterial ophthalmic solutions could ... Delayed corneal wound healing resulting from the administration of fluoroquinolone antibacterial ophthalmic solutions and its ... Delayed corneal wound healing resulting from the administration of fluoroquinolone antibacterial ophthalmic solutions and its ...
more infohttps://iovs.arvojournals.org/article.aspx?articleid=2149150
Xalatan, Xelpros (latanoprost) dosing, indications, interactions, adverse effects, and more  Xalatan, Xelpros (latanoprost) dosing, indications, interactions, adverse effects, and more
Administration. Ophthalmic Administration. Missed dose. *One dose missed: Continue treatment with next dose as normal ... Concomitant use with other ophthalmic prostaglandin analogs and topical ophthalmic drug products to lower intraocular pressure ... Bacterial keratitis may result from inadvertent contamination of multidose ophthalmic solutions. Gradual changes in eyelashes ... Combined use of ≥2 prostaglandins, or prostaglandin analogs not recommended; administration of prostaglandin drug products more ...
more infohttps://reference.medscape.com/drug/xalatan-latanoprost-343606
Patent US20110152767 - Method and Apparatus for Drug Delivery - Google Patentsuche  Patent US20110152767 - Method and Apparatus for Drug Delivery - Google Patentsuche
Methods of ophthalmic administration. US6520930 *. 3. Apr. 2001. 18. Febr. 2003. Medrad, Inc.. Injectors, injector systems and ... Ophthalmic Injection Method. US20080097379 *. 26. Sept. 2006. 24. Apr. 2008. Alcon Manufacturing, Ltd.. Ophthalmic injection ... Ophthalmic Injection Device Including Dosage Control Device. US20100057003 *. 9. Okt. 2007. 4. M rz 2010. Cesario Dos Santos. ... Method of Operating Ophthalmic Hand Piece with Disposable End. US20100106089 *. 1. Okt. 2007. 29. Apr. 2010. Cesario Dos Santos ...
more infohttp://www.google.de/patents/US20110152767
Patent US4534348 - Instrument for making corneal incisions - Google Patents  Patent US4534348 - Instrument for making corneal incisions - Google Patents
Methods of ophthalmic administration. US6397849. Aug 2, 1999. Jun 4, 2002. Insite Vision Incorporated. Methods of ophthalmic ...
more infohttp://www.google.com/patents/US4534348
Optrex Allergy 2% w/v Eye Drops, Solution (eye drops) - Summary of Product Characteristics (SmPC) - (eMC)  Optrex Allergy 2% w/v Eye Drops, Solution (eye drops) - Summary of Product Characteristics (SmPC) - (eMC)
4.2 Posology and method of administration. Topical ophthalmic administration One or two drops in each eye four times a day or ... As with other ophthalmic solutions containing benzalkonium chloride, soft contact lenses should not be worn during the ... When multiple doses of sodium cromoglicate ophthalmic solution are instilled into normal rabbit eyes, less than 0.07% of the ... of sodium cromoglicate is absorbed following administration to the eye. ...
more infohttps://www.medicines.org.uk/emc/product/1945/smpc
Patent US8617094 - Fluid infusion methods for glaucoma treatment -  Google Patent  Patent US8617094 - Fluid infusion methods for glaucoma treatment - Google Patent
Methods of ophthalmic administration. US6413540. 12 sep 2000. 2 jul 2002. Alcon Universal Ltd.. Drug delivery device. ... Ophthalmic device for draining excess intraocular fluid. US5629008. 7 jun 1994. 13 maj 1997. C.R. Bard, Inc.. Method and device ... Method of treating ophthalmic disorders using TGF -β. US5785674. 20 dec 1996. 28 jul 1998. Mateen; Ahmed Abdul. Device and ... Device and method for treating ophthalmic diseases. US6306120. 7 jun 1999. 23 okt 2001. Ben Gee Tan. Applicator and method for ...
more infohttp://www.google.se/patents/US8617094
Drug Summary  Drug Summary
Ophthalmic Administration. Instruct patient on proper instillation of eye solution.. Do not to touch the tip of the dropper to ... There have been reports that ophthalmic administration of diclofenac may cause increased bleeding of ocular tissues (including ... Ophthalmic Route. Systemic absorption from the ophthalmic formulation is not clinically significant. ... Administration of a CYP2C9 substrate, tolbutamide, on days 1, 4, 8, and 15 with a 3-day regimen of oral aprepitant (125 mg/80 ...
more infohttp://www.pdr.net/drug-summary/Cambia-diclofenac-potassium-2426
AzaSite (azithromycin) dose, indications, adverse effects, interactions... from PDR.net  AzaSite (azithromycin) dose, indications, adverse effects, interactions... from PDR.net
Ophthalmic Administration. AzaSite is for ophthalmic use only. Apply topically only to the eye.. Instruct patient on proper ... Ophthalmic Route. Following application of one drop of azithromycin ophthalmic solution to each eye, the systemic concentration ... Administration of the ER oral suspension with a high-fat meal increases azithromycin mean Cmax by 115% and mean AUC by 23% ... After administration of the extended-release (ER) oral suspension, the mean Cmax and AUC of azithromycin were lower by 57% and ...
more infohttps://www.pdr.net/drug-summary/AzaSite-azithromycin-2194
Ophthalmology and Therapy | springermedizin.de  Ophthalmology and Therapy | springermedizin.de
Pharmacokinetics of Azithromycin, Levofloxacin, and Ofloxacin in Rabbit Extraocular Tissues After Ophthalmic Administration. ... Practice Patterns in Orbital Decompression Surgery Among American Society of Ophthalmic Plastic and Reconstructive Surgery ...
more infohttps://www.springermedizin.de/ophthalmology-and-therapy/9339918
US7699882B2 - Apparatus and method for surgical bypass of aqueous humor 
        - Google Patents  US7699882B2 - Apparatus and method for surgical bypass of aqueous humor - Google Patents
Methods of ophthalmic administration US6112747A (en) * 1998-11-06. 2000-09-05. Jones; Jesse M.. Method of sterilizing females ... Ophthalmic microsurgical system US8425449B2 (en) 2013-04-23. Ocular implants and methods for delivering ocular implants into ... Composite Ophthalmic Mikrokanuele US20070244520A1 (en) * 2004-04-19. 2007-10-18. Searete Llc. Lumen-traveling biological ... Methods and means for drug administration EP0723786A1 (en) * 1995-01-30. 1996-07-31. Cardiovascular Concepts, Inc.. Lesion ...
more infohttps://patents.google.com/patent/US7699882B2/en
US7094226B2 - Ophthalmic drug delivery device 
        - Google Patents  US7094226B2 - Ophthalmic drug delivery device - Google Patents
An ophthalmic drug delivery device having a first end and a second end, an injection port, a reservoir, and a sleeve is ... Methods of ophthalmic administration US6397849B1 (en) 1998-08-03. 2002-06-04. Insite Vision Incorporated. Methods of ophthalmic ... "A New method for Posterior Sub-Tenon's Drug Administration," Nesterov, et al., Ophthalmic Surgery, vol. 24, No. 1, Jan. 1993, ... US7094226B2 - Ophthalmic drug delivery device - Google Patents. Ophthalmic drug delivery device Download PDF Info. Publication ...
more infohttps://patents.google.com/patent/US7094226B2/en
  • wheezing or trouble breathing Hypersensitivity to other sulfonamides Acute angle-closure glaucoma Concomitant administration of oral carbonic anhydrase inhibitors Moderate-to-severe renal or hepatic insufficiency The combination of brinzolamide with timolol is marketed under the trade name Azarga. (wikipedia.org)
  • Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability. (wikipedia.org)
  • An ophthalmic drug delivery device having a first end and a second end, an injection port, a reservoir, and a sleeve is disclosed. (google.com)